Michael Kalos
Directeur/Membre du Conseil chez IMV INC.
Fortune : - $ au 31/12/2023
Postes actifs de Michael Kalos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMV INC. | Directeur/Membre du Conseil | 11/05/2021 | - |
| Independent Dir/Board Member | 11/05/2021 | - | |
| Next Pillar Consulting, LLC | Directeur Général | - | - |
Historique de carrière de Michael Kalos
Anciens postes connus de Michael Kalos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - | - |
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | - | - |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Michael Kalos
| University of Minnesota | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| IMV INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
| Next Pillar Consulting, LLC |
- Bourse
- Insiders
- Michael Kalos
- Expérience
